Literature DB >> 7850857

Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system.

J R Moffett1, M G Espey, M A Namboodiri.   

Abstract

Antibodies to quinolinic acid were produced in rabbits with protein-conjugated and gold particle-adsorbed quinolinic acid. Quinolinic acid immunoreactivity was below detection limits in carbodiimide-fixed rat brain. In contrast, strong quinolinic acid immunoreactivity was observed in spleen cells with variable, complex morphology located predominantly in the periarterial lymphocyte sheaths. In the thymus, quinolinic acid immunoreactivity was observed in cells with variable morphology, located almost exclusively in the medulla. Lymph nodes and gut-associated lymphoid tissue contained many, strongly stained cells of similar complex morphology in perifollicular areas. Immunoreactivity in liver and lung was restricted to widely scattered, perivascular cells and alveolar cells respectively. Additional stained cells with complex morphology were observed in bronchus-associated lymphoid tissue, in skin, and in the lamina propria of intestinal villi. Follicles in all secondary lymphoid organs were diffusely stained, ranging from mildly to moderately immunoreactive in spleen, to intensely immunoreactive in gut-associated lymphoid tissue. These results suggest that quinolinic acid is an immune system-specific molecule. Two hypothetical schemes are proposed to account for high levels of quinolinic acid in specific cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850857     DOI: 10.1007/bf00331364

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  34 in total

1.  Induction of indoleamine 2,3-dioxygenase in human cells in vitro.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  Excitotoxic models for neurodegenerative disorders.

Authors:  R Schwarcz; A C Foster; E D French; W O Whetsell; C Köhler
Journal:  Life Sci       Date:  1984-07-02       Impact factor: 5.037

3.  Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.

Authors:  R Yoshida; Y Urade; M Tokuda; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.

Authors:  A C Foster; L P Miller; W H Oldendorf; R Schwarcz
Journal:  Exp Neurol       Date:  1984-05       Impact factor: 5.330

5.  Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain.

Authors:  J R Moffett; M A Namboodiri; J H Neale
Journal:  J Histochem Cytochem       Date:  1993-04       Impact factor: 2.479

6.  4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).

Authors:  K Saito; C Y Chen; M Masana; J S Crowley; S P Markey; M P Heyes
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

7.  Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.

Authors:  M P Heyes; K Saito; D Jacobowitz; S P Markey; O Takikawa; J H Vickers
Journal:  FASEB J       Date:  1992-08       Impact factor: 5.191

8.  Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

Authors:  M P Heyes; K Saito; J S Crowley; L E Davis; M A Demitrack; M Der; L A Dilling; J Elia; M J Kruesi; A Lackner
Journal:  Brain       Date:  1992-10       Impact factor: 13.501

9.  Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.

Authors:  S Fukui; R Schwarcz; S I Rapoport; Y Takada; Q R Smith
Journal:  J Neurochem       Date:  1991-06       Impact factor: 5.372

10.  Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading.

Authors:  M J During; M P Heyes; A Freese; S P Markey; J B Martin; R H Roth
Journal:  Brain Res       Date:  1989-01-09       Impact factor: 3.252

View more
  12 in total

1.  Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.

Authors:  Duygu Eryavuz Onmaz; Dilek Tezcan; Sedat Abusoglu; Abdullah Sivrikaya; Menekse Kuzu; Fatma Humeyra Yerlikaya; Sema Yilmaz; Ali Unlu
Journal:  Amino Acids       Date:  2022-05-23       Impact factor: 3.520

Review 2.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.

Authors:  C N Venkateshan; R Narayanan; M G Espey; J R Moffett; D C Gajdusek; C J Gibbs; M A Namboodiri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.

Authors:  Flaviano Giorgini; Shao-Yi Huang; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Marian A R Thomas; Margarita Tararina; Hui-Qiu Wu; Robert Schwarcz; Paul J Muchowski
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

5.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

Review 6.  The end of the road for the tryptophan depletion concept in pregnancy and infection.

Authors:  Abdulla A-B Badawy; Aryan M A Namboodiri; John R Moffett
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

Review 7.  Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase.

Authors:  Kashif Asghar; Asim Farooq; Bilal Zulfiqar; Asif Loya
Journal:  World J Clin Oncol       Date:  2021-06-24

8.  Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Authors:  Peter Terness; Thomas M Bauer; Lars Röse; Christoph Dufter; Andrea Watzlik; Helmut Simon; Gerhard Opelz
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

9.  Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.

Authors:  Min-Jung Park; So-Youn Min; Kyung-Su Park; Young-Gyu Cho; Mi-La Cho; Young-Ok Jung; Hyun-Sil Park; Soog-Hee Chang; Seok Goo Cho; Jun-Ki Min; Sung-Hwan Park; Ho-Youn Kim
Journal:  Arthritis Res Ther       Date:  2008-01-25       Impact factor: 5.156

10.  Indoleamine 2,3-dioxygenase (IDO) is expressed at feto-placental unit throughout mouse gestation: An immunohistochemical study.

Authors:  Hemmati Shayda; Jeddi-Tehrani Mahmood; Torkabadi Ebrahim; Ghassemi Jamileh; Kazemi Sefat Golnaz Ensieh; Danesh Parivash; Barzegar Yarmohammadi Leila; Akhondi Mohammad Mehdi; Zarnani Amir Hassan
Journal:  J Reprod Infertil       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.